Research and regulatory
📋 Development stage
In Phase 3 clinical trials for obesity and MASH (metabolic dysfunction-associated steatohepatitis) as of 2026; not yet FDA approved.
⚖️ Legal and regulatory
Investigational compound; not FDA approved.
⚠️ Side effects
GI symptoms (most common), nausea